glp-1 advertising policy news Compounded Drugs and its Legally Murky Advertisements – Fourteen East GLP-1 Law & Policy

I noticed immediate improvement with my one cat and slower improvement on my 2nd cat Both are doing well and have gained weight

Weight loss drug Wegovy to be subsidised for Australians with severe obesity Mon 12 Jan 2026 at 6:00am , updated Mon 12 Jan 2026 at 11:25am In short: The cost of weight loss drug Wegovy will soon be massively subsidised for Australians with severe obesity who have had a stroke or heart attack

However, we dont know if its for semaglutide or tirzepatide and if its weekly or monthly

The fixes are in the FAQ below

The anchoring trials are the STEP program (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)

Decreasing waist circumference with stable or increasing limb measurements suggests favorable fat loss with lean mass preservation